Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SiShield Technologies is a private U.S. antimicrobial materials and chemical technology company that develops, manufactures, and commercializes water-based, EPA-registered formulations designed to bond to surfaces and materials during manufacturing. Its technology is based on a silane-derived antimicrobial chemistry created by founder Jacques Elfersy and is marketed through SiShield antimicrobial solutions and the Miracle Fresh odor-control brand. The company focuses on durable, non-leaching, non-toxic microbial control for applications across textiles, healthcare-related surfaces, building materials, consumer products, and infrastructure. SiShield positions itself as a platform provider that custom-engineers antimicrobial and odor-management solutions for partners rather than as a therapeutic drug developer. Recent product activity includes Miracle Fresh Plus for textile odor control and moisture management, alongside antimicrobial solutions used in applications such as sewer infrastructure protection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SiShield Technologies.